|
pubmed:abstractText |
Zinc has been reported to ameliorate hematologic side effects and improve liver function. In addition to its various effects, zinc supplementation in chronic hepatitis C patients with genotype 1b of high viral load enhanced the response to interferon (IFN) monotherapy. This study was aimed at clarifying whether zinc could improve hematologic side effects, improve liver function, and enhance the response to therapy in patients with chronic hepatitis C treated with pegylated-interferon (PEG-IFN) plus ribavirin (RBV).
|
|
pubmed:affiliation |
Department of Pharmacy, Kobe Asahi Hospital, 3-5-25, Bououji-cho, Nagata-ku, Kobe Hyogo, 653-0801, Japan, info@kobe-asahi-hp.com.
|
